This week thanks to the involvement of CSIRO, Oventus Medical was just listed on the Australian Securities Exchange. The newly public company was able to raise more than $12 million AUS ($9 million USD) in its initial public offering, which the company plans to reinvest into the commercialization and global distribution of their O2Vent sleep apnea device. The customizable titanium mouth device helps patients suffering with sleep apnea to breathe while sleeping without obstruction. The first prototype for the O2Vent was 3D printed in titanium at CSIRO’s Lab 22 Innovation Centre located in Victoria using an Arcam metal 3D printer. You can read more over on 3Dprint.com: https://3dprint.com/143205/oventus-csiro-sleep-apnea/